Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03048136
Title A Safety Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Non-small Cell Lung Cancer (CheckMate 955)
Acronym CheckMate 955
Recruitment Withdrawn
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Bristol-Myers Squibb
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | DEU | CAN | ARG

Facility Status City State Zip Country Details
Local Institution San Francisco California 94115 United States Details
Local Institution Lincoln Nebraska 68506 United States Details
Local Institution Hackensack New Jersey 07601 United States Details
Local Institution Columbus Ohio 43210 United States Details
Local Institution Lancaster Pennsylvania 17604 United States Details
Local Institution Langhorne Pennsylvania 19047 United States Details
Local Institution Sayre Pennsylvania 18840 United States Details
Local Institution Charleston South Carolina 29414 United States Details
Local Institution Saint George Utah 84770 United States Details
Local Institution Viedma RIO Negro 8500 Argentina Details
Local Institution Montreal Quebec H1M 1B1 Canada Details
Local Institution Dresden 01307 Germany Details
Local Institution Gauting 82131 Germany Details
Local Institution Gerlingen 70839 Germany Details
Local Institution Grosshansdorf 22927 Germany Details
Local Institution Lima 27 Peru Details
Local Institution Lima Peru Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field